| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration—A Review of Clinical Outcomes
|
Russell, Stephen R.
|
|
2007
|
|
1S |
p. S79-S90
12 p.
|
artikel
|
| 2 |
Clinical Safety Profile of Posterior Juxtascleral Depot Administration of Anecortave Acetate 15 mg Suspension as Primary Therapy or Adjunctive Therapy with Photodynamic Therapy for Treatment of Wet Age-Related Macular Degeneration
|
Regillo, Carl D.
|
|
2007
|
|
1S |
p. S70-S78
9 p.
|
artikel
|
| 3 |
Introduction
|
Clark, Abbot F.
|
|
2007
|
|
1S |
p. S1-S2
2 p.
|
artikel
|
| 4 |
Mechanism of Action of the Angiostatic Cortisene Anecortave Acetate
|
Clark, Abbot F.
|
|
2007
|
|
1S |
p. S26-S34
9 p.
|
artikel
|
| 5 |
Ocular Neovascularization: Basic Mechanisms and Therapeutic Advances
|
Dorrell, Michael
|
|
2007
|
|
1S |
p. S3-S19
17 p.
|
artikel
|
| 6 |
Pharmacokinetics and Metabolism of Anecortave Acetate in Animals and Humans
|
Dahlin, David C.
|
|
2007
|
|
1S |
p. S49-S61
13 p.
|
artikel
|
| 7 |
Posterior Juxtascleral Depot Administration of Anecortave Acetate
|
Kaiser, Peter K.
|
|
2007
|
|
1S |
p. S62-S69
8 p.
|
artikel
|
| 8 |
Preclinical Efficacy of Anecortave Acetate
|
Clark, Abbot F.
|
|
2007
|
|
1S |
p. S41-S48
8 p.
|
artikel
|
| 9 |
Preclinical Safety of Anecortave Acetate
|
Heaton, Jim
|
|
2007
|
|
1S |
p. S35-S40
6 p.
|
artikel
|
| 10 |
Quality of Life and Health Economic Assessments of Age-Related Macular Degeneration
|
Covert, David
|
|
2007
|
|
1S |
p. S20-S25
6 p.
|
artikel
|
| 11 |
The Digital Angiography Reading Center (DARC) Role in the Anecortave Acetate Clinical Trials
|
Slakter, Jason S.
|
|
2007
|
|
1S |
p. S91-S98
8 p.
|
artikel
|
Tijdschrift beschrijving